Immucor is dedicated to offering products that enable patients anywhere who are in need of blood or an organ to receive the right match that is safe, accessible and affordable. The result is life changing for a patient in need of a transfusion or transplant. Immucor is a leading provider of transfusion and transplantation diagnostic products worldwide. Our new corporate identity illustrates the right match of donors with patients in need of blood or an organ as well as Immucor’s partnership with healthcare organizations in need of innovation and productivity.
Type
Private
HQ
Norcross, US
Founded
1982
Size (employees)
909 (est)+2%
Immucor was founded in 1982 and is headquartered in Norcross, US
Report incorrect company information

Key People/Management at Immucor

Avi Pelossof

Avi Pelossof

President and Chief Executive Officer

Immucor Office Locations

Immucor has an office in Norcross
Norcross, US (HQ)
3130 Gateway Dr
Show all (1)
Report incorrect company information

Immucor Financials and Metrics

Summary Metrics

Founding Date

1982

Immucor Financials

Immucor's revenue was reported to be $379.97 m in FY, 2016
USD

Revenue (Q3, 2017)

94 m

Gross profit (Q3, 2017)

94 m

Gross profit margin (Q3, 2017), %

100%

Net income (Q3, 2017)

(32.3 m)

EBIT (Q3, 2017)

8.1 m

Cash (2-Feb-2018)

10 m
Annual
USDFY, 2016

Revenue

380 m

Cost of goods sold

144 m

Gross profit

236 m

Gross profit Margin, %

62%
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

102.4 m96.3 m95.6 m96.7 m96.2 m88.9 m98.6 m93.7 m94 m

Cost of goods sold

36.8 m35.8 m34 m34.6 m37.9 m34.1 m38.2 m

Gross profit

65.6 m60.5 m61.6 m62.1 m58.4 m54.8 m98.6 m55.5 m94 m

Gross profit Margin, %

64%63%64%64%61%62%100%59%100%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

23.6 m18.4 m10.3 m

Accounts Receivable

62 m

Inventories

49.2 m11.2 m46.9 m

Current Assets

163.2 m145 m127.7 m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

19 m15.1 m12.2 m9.7 m10.5 m10 m

Inventories

48.5 m44.7 m47.8 m49.3 m47.3 m48.9 m

Current Assets

149.3 m140.6 m135.8 m133.2 m125.3 m131.9 m

PP&E

73.3 m72.2 m72.8 m75.9 m76.3 m76.8 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(6.4 m)(60.7 m)(43.8 m)

Depreciation and Amortization

50.8 m50.8 m54.9 m

Inventories

(3.1 m)(12 m)

Accounts Payable

(1.4 m)8.3 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(5.5 m)(14.6 m)(54 m)(7.2 m)(19 m)(27.7 m)(10.1 m)(22.9 m)(32.3 m)

Depreciation and Amortization

18.4 m36.1 m53.8 m17 m34.2 m51.4 m18.2 m36.2 m54.1 m

Inventories

(1.8 m)(2.4 m)(6 m)(7.9 m)(6.2 m)(11 m)(3.9 m)(4.1 m)(8.3 m)

Accounts Payable

2.1 m2.7 m(3.3 m)2.2 m(187 k)4.2 m(4.1 m)(4.3 m)(779 k)
USDY, 2017

Revenue/Employee

107.8 k

Financial Leverage

5.4 x
Show all financial metrics
Report incorrect company information